Vascular thiol isomerases: Structures, regulatory mechanisms, and inhibitor development
Drug Discovery Today, ISSN: 1359-6446, Vol: 27, Issue: 2, Page: 626-635
2022
- 8Citations
- 9Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations8
- Citation Indexes8
- CrossRef5
- Captures9
- Readers9
Review Description
Vascular thiol isomerases (VTIs), including PDI, ERp5, ERp57, ERp72, and thioredoxin-related transmembrane protein 1 (TMX1), have important roles in platelet aggregation and thrombosis. Research on VTIs, their substrates in thrombosis, their regulatory mechanisms, and inhibitor development is an emerging and rapidly evolving area in vascular biology. Here, we describe the structures and functions of VTIs, summarize the relationship between the vascular TIs and thrombosis, and focus on the development of VTI inhibitors for antithrombotic applications.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1359644621004566; http://dx.doi.org/10.1016/j.drudis.2021.10.018; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85119200543&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/34757205; https://linkinghub.elsevier.com/retrieve/pii/S1359644621004566; https://dx.doi.org/10.1016/j.drudis.2021.10.018
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know